FDA risk communication strategy
This article was originally published in The Tan Sheet
Executive Summary
The Risk Communication Advisory Committee discusses the agency's draft risk communication strategic plan and offers further advice on strategic priorities for research on effective risk communication in a meeting scheduled for April 30 and May 1. Presentations from the public are scheduled between 1 p.m. and 2 p.m. the first day and 10:30 a.m. to 11:30 a.m. the next day during the meeting at an FDA facility in Rockville, Md., according to a March 5 Federal Register notice. At its previous meeting, the committee emphasized that FDA should assess its communications to ensure safe and effective use of medical products (1"The Tan Sheet" Sept. 1, 2008, p. 8)
|
The Risk Communication Advisory Committee discusses the agency's draft risk communication strategic plan and offers further advice on strategic priorities for research on effective risk communication in a meeting scheduled for April 30 and May 1. Presentations from the public are scheduled between 1 p.m. and 2 p.m. the first day and 10:30 a.m. to 11:30 a.m. the next day during the meeting at an FDA facility in Rockville, Md., according to a March 5 Federal Register notice. At its previous meeting, the committee emphasized that FDA should assess its communications to ensure safe and effective use of medical products (1 (Also see "FDA Risk Communication Research May Follow Critical Path To Avoid OMB" - Pink Sheet, 1 Sep, 2008.), p. 8). |